Order Article Reprints

Kao Y-T, Liu Y-C, Cheng Y-T, Wen Y-W, Hsieh Y-C, Hsu C-E, Su C-W, Tai JC-H, Chen Y-C, Jeng W-J, et al. Hepatocellular Carcinoma Incidences and Risk Factors in Hepatitis C Patients: Interferon versus Direct-Acting Agents. Viruses. 2024; 16(9):1485. https://doi.org/10.3390/v16091485

Kao, Yu-Ting, Yen-Chun Liu, Ya-Ting Cheng, Yu-Wen Wen, Yi-Chung Hsieh, Cheng-Er Hsu, Chung-Wei Su, Jennifer Chia-Hung Tai, Yi-Cheng Chen, Wen-Juei Jeng, and et al. 2024. "Hepatocellular Carcinoma Incidences and Risk Factors in Hepatitis C Patients: Interferon versus Direct-Acting Agents" Viruses 16, no. 9: 1485. https://doi.org/10.3390/v16091485

Kao, Y.-T., Liu, Y.-C., Cheng, Y.-T., Wen, Y.-W., Hsieh, Y.-C., Hsu, C.-E., Su, C.-W., Tai, J. C.-H., Chen, Y.-C., Jeng, W.-J., Lin, C.-Y., Chien, R.-N., Tai, D.-I., & Sheen, I.-S. (2024). Hepatocellular Carcinoma Incidences and Risk Factors in Hepatitis C Patients: Interferon versus Direct-Acting Agents. Viruses, 16(9), 1485. https://doi.org/10.3390/v16091485